National Pharmacare in Canada: a one-size-fits all solution?
Canada’s healthcare system is viewed as a “universal” one, founded on the basis of equal access rather than the ability to pay, though the reality is somewhat...
Ashley Fraser is a Principal in the Life Sciences Practice of Charles River Associates. She has nine years of experience advising pharmaceutical, biotech, and medical device organizations.
Her consulting experience includes pricing, reimbursement and market access strategies across the product development lifecycle, payer engagement, lifecycle management, and optimization of internal P&MA processes and team structures. Her engagements cover a range of therapeutic areas and emphasize Canada, US, and EU5 among other Global markets. Prior to her role at CRA, Ms. Fraser was an Associate Principal at QuintilesIMS.